Medical Care
Global Gene Detection for Individualized Cancer Therapy Market Research Report 2025
- Jul 08, 25
- ID: 347444
- Pages: 74
- Figures: 74
- Views: 2
The global market for Gene Detection for Individualized Cancer Therapy was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
A method to provide patients with individualized treatment of cancer tumors
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Gene Detection for Individualized Cancer Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gene Detection for Individualized Cancer Therapy.
The Gene Detection for Individualized Cancer Therapy market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Gene Detection for Individualized Cancer Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Gene Detection for Individualized Cancer Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Premed
Yin Feng Gene
United Gene Group
Geneis
Topgen
Annoroad
Gene+
Sanvalley
Sansure
Segment by Type
Genetic Screening
Reproductive Genetic Testing
Diagnostic Test
Gene carrier Test
Testing Before Symptoms Appear
Segment by Application
Hospital
Clinic
Diagnostic Center
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Gene Detection for Individualized Cancer Therapy company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
A method to provide patients with individualized treatment of cancer tumors
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Gene Detection for Individualized Cancer Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gene Detection for Individualized Cancer Therapy.
The Gene Detection for Individualized Cancer Therapy market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Gene Detection for Individualized Cancer Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Gene Detection for Individualized Cancer Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Premed
Yin Feng Gene
United Gene Group
Geneis
Topgen
Annoroad
Gene+
Sanvalley
Sansure
Segment by Type
Genetic Screening
Reproductive Genetic Testing
Diagnostic Test
Gene carrier Test
Testing Before Symptoms Appear
Segment by Application
Hospital
Clinic
Diagnostic Center
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Gene Detection for Individualized Cancer Therapy company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Gene Detection for Individualized Cancer Therapy Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Genetic Screening
1.2.3 Reproductive Genetic Testing
1.2.4 Diagnostic Test
1.2.5 Gene carrier Test
1.2.6 Testing Before Symptoms Appear
1.3 Market by Application
1.3.1 Global Gene Detection for Individualized Cancer Therapy Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Diagnostic Center
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Gene Detection for Individualized Cancer Therapy Market Perspective (2020-2031)
2.2 Global Gene Detection for Individualized Cancer Therapy Growth Trends by Region
2.2.1 Global Gene Detection for Individualized Cancer Therapy Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Gene Detection for Individualized Cancer Therapy Historic Market Size by Region (2020-2025)
2.2.3 Gene Detection for Individualized Cancer Therapy Forecasted Market Size by Region (2026-2031)
2.3 Gene Detection for Individualized Cancer Therapy Market Dynamics
2.3.1 Gene Detection for Individualized Cancer Therapy Industry Trends
2.3.2 Gene Detection for Individualized Cancer Therapy Market Drivers
2.3.3 Gene Detection for Individualized Cancer Therapy Market Challenges
2.3.4 Gene Detection for Individualized Cancer Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Gene Detection for Individualized Cancer Therapy Players by Revenue
3.1.1 Global Top Gene Detection for Individualized Cancer Therapy Players by Revenue (2020-2025)
3.1.2 Global Gene Detection for Individualized Cancer Therapy Revenue Market Share by Players (2020-2025)
3.2 Global Gene Detection for Individualized Cancer Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Gene Detection for Individualized Cancer Therapy Revenue
3.4 Global Gene Detection for Individualized Cancer Therapy Market Concentration Ratio
3.4.1 Global Gene Detection for Individualized Cancer Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Gene Detection for Individualized Cancer Therapy Revenue in 2024
3.5 Global Key Players of Gene Detection for Individualized Cancer Therapy Head office and Area Served
3.6 Global Key Players of Gene Detection for Individualized Cancer Therapy, Product and Application
3.7 Global Key Players of Gene Detection for Individualized Cancer Therapy, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Gene Detection for Individualized Cancer Therapy Breakdown Data by Type
4.1 Global Gene Detection for Individualized Cancer Therapy Historic Market Size by Type (2020-2025)
4.2 Global Gene Detection for Individualized Cancer Therapy Forecasted Market Size by Type (2026-2031)
5 Gene Detection for Individualized Cancer Therapy Breakdown Data by Application
5.1 Global Gene Detection for Individualized Cancer Therapy Historic Market Size by Application (2020-2025)
5.2 Global Gene Detection for Individualized Cancer Therapy Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Gene Detection for Individualized Cancer Therapy Market Size (2020-2031)
6.2 North America Gene Detection for Individualized Cancer Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Gene Detection for Individualized Cancer Therapy Market Size by Country (2020-2025)
6.4 North America Gene Detection for Individualized Cancer Therapy Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Gene Detection for Individualized Cancer Therapy Market Size (2020-2031)
7.2 Europe Gene Detection for Individualized Cancer Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Gene Detection for Individualized Cancer Therapy Market Size by Country (2020-2025)
7.4 Europe Gene Detection for Individualized Cancer Therapy Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Gene Detection for Individualized Cancer Therapy Market Size (2020-2031)
8.2 Asia-Pacific Gene Detection for Individualized Cancer Therapy Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Gene Detection for Individualized Cancer Therapy Market Size by Region (2020-2025)
8.4 Asia-Pacific Gene Detection for Individualized Cancer Therapy Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Gene Detection for Individualized Cancer Therapy Market Size (2020-2031)
9.2 Latin America Gene Detection for Individualized Cancer Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Gene Detection for Individualized Cancer Therapy Market Size by Country (2020-2025)
9.4 Latin America Gene Detection for Individualized Cancer Therapy Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Gene Detection for Individualized Cancer Therapy Market Size (2020-2031)
10.2 Middle East & Africa Gene Detection for Individualized Cancer Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Gene Detection for Individualized Cancer Therapy Market Size by Country (2020-2025)
10.4 Middle East & Africa Gene Detection for Individualized Cancer Therapy Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Premed
11.1.1 Premed Company Details
11.1.2 Premed Business Overview
11.1.3 Premed Gene Detection for Individualized Cancer Therapy Introduction
11.1.4 Premed Revenue in Gene Detection for Individualized Cancer Therapy Business (2020-2025)
11.1.5 Premed Recent Development
11.2 Yin Feng Gene
11.2.1 Yin Feng Gene Company Details
11.2.2 Yin Feng Gene Business Overview
11.2.3 Yin Feng Gene Gene Detection for Individualized Cancer Therapy Introduction
11.2.4 Yin Feng Gene Revenue in Gene Detection for Individualized Cancer Therapy Business (2020-2025)
11.2.5 Yin Feng Gene Recent Development
11.3 United Gene Group
11.3.1 United Gene Group Company Details
11.3.2 United Gene Group Business Overview
11.3.3 United Gene Group Gene Detection for Individualized Cancer Therapy Introduction
11.3.4 United Gene Group Revenue in Gene Detection for Individualized Cancer Therapy Business (2020-2025)
11.3.5 United Gene Group Recent Development
11.4 Geneis
11.4.1 Geneis Company Details
11.4.2 Geneis Business Overview
11.4.3 Geneis Gene Detection for Individualized Cancer Therapy Introduction
11.4.4 Geneis Revenue in Gene Detection for Individualized Cancer Therapy Business (2020-2025)
11.4.5 Geneis Recent Development
11.5 Topgen
11.5.1 Topgen Company Details
11.5.2 Topgen Business Overview
11.5.3 Topgen Gene Detection for Individualized Cancer Therapy Introduction
11.5.4 Topgen Revenue in Gene Detection for Individualized Cancer Therapy Business (2020-2025)
11.5.5 Topgen Recent Development
11.6 Annoroad
11.6.1 Annoroad Company Details
11.6.2 Annoroad Business Overview
11.6.3 Annoroad Gene Detection for Individualized Cancer Therapy Introduction
11.6.4 Annoroad Revenue in Gene Detection for Individualized Cancer Therapy Business (2020-2025)
11.6.5 Annoroad Recent Development
11.7 Gene+
11.7.1 Gene+ Company Details
11.7.2 Gene+ Business Overview
11.7.3 Gene+ Gene Detection for Individualized Cancer Therapy Introduction
11.7.4 Gene+ Revenue in Gene Detection for Individualized Cancer Therapy Business (2020-2025)
11.7.5 Gene+ Recent Development
11.8 Sanvalley
11.8.1 Sanvalley Company Details
11.8.2 Sanvalley Business Overview
11.8.3 Sanvalley Gene Detection for Individualized Cancer Therapy Introduction
11.8.4 Sanvalley Revenue in Gene Detection for Individualized Cancer Therapy Business (2020-2025)
11.8.5 Sanvalley Recent Development
11.9 Sansure
11.9.1 Sansure Company Details
11.9.2 Sansure Business Overview
11.9.3 Sansure Gene Detection for Individualized Cancer Therapy Introduction
11.9.4 Sansure Revenue in Gene Detection for Individualized Cancer Therapy Business (2020-2025)
11.9.5 Sansure Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Gene Detection for Individualized Cancer Therapy Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Genetic Screening
1.2.3 Reproductive Genetic Testing
1.2.4 Diagnostic Test
1.2.5 Gene carrier Test
1.2.6 Testing Before Symptoms Appear
1.3 Market by Application
1.3.1 Global Gene Detection for Individualized Cancer Therapy Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Diagnostic Center
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Gene Detection for Individualized Cancer Therapy Market Perspective (2020-2031)
2.2 Global Gene Detection for Individualized Cancer Therapy Growth Trends by Region
2.2.1 Global Gene Detection for Individualized Cancer Therapy Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Gene Detection for Individualized Cancer Therapy Historic Market Size by Region (2020-2025)
2.2.3 Gene Detection for Individualized Cancer Therapy Forecasted Market Size by Region (2026-2031)
2.3 Gene Detection for Individualized Cancer Therapy Market Dynamics
2.3.1 Gene Detection for Individualized Cancer Therapy Industry Trends
2.3.2 Gene Detection for Individualized Cancer Therapy Market Drivers
2.3.3 Gene Detection for Individualized Cancer Therapy Market Challenges
2.3.4 Gene Detection for Individualized Cancer Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Gene Detection for Individualized Cancer Therapy Players by Revenue
3.1.1 Global Top Gene Detection for Individualized Cancer Therapy Players by Revenue (2020-2025)
3.1.2 Global Gene Detection for Individualized Cancer Therapy Revenue Market Share by Players (2020-2025)
3.2 Global Gene Detection for Individualized Cancer Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Gene Detection for Individualized Cancer Therapy Revenue
3.4 Global Gene Detection for Individualized Cancer Therapy Market Concentration Ratio
3.4.1 Global Gene Detection for Individualized Cancer Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Gene Detection for Individualized Cancer Therapy Revenue in 2024
3.5 Global Key Players of Gene Detection for Individualized Cancer Therapy Head office and Area Served
3.6 Global Key Players of Gene Detection for Individualized Cancer Therapy, Product and Application
3.7 Global Key Players of Gene Detection for Individualized Cancer Therapy, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Gene Detection for Individualized Cancer Therapy Breakdown Data by Type
4.1 Global Gene Detection for Individualized Cancer Therapy Historic Market Size by Type (2020-2025)
4.2 Global Gene Detection for Individualized Cancer Therapy Forecasted Market Size by Type (2026-2031)
5 Gene Detection for Individualized Cancer Therapy Breakdown Data by Application
5.1 Global Gene Detection for Individualized Cancer Therapy Historic Market Size by Application (2020-2025)
5.2 Global Gene Detection for Individualized Cancer Therapy Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Gene Detection for Individualized Cancer Therapy Market Size (2020-2031)
6.2 North America Gene Detection for Individualized Cancer Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Gene Detection for Individualized Cancer Therapy Market Size by Country (2020-2025)
6.4 North America Gene Detection for Individualized Cancer Therapy Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Gene Detection for Individualized Cancer Therapy Market Size (2020-2031)
7.2 Europe Gene Detection for Individualized Cancer Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Gene Detection for Individualized Cancer Therapy Market Size by Country (2020-2025)
7.4 Europe Gene Detection for Individualized Cancer Therapy Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Gene Detection for Individualized Cancer Therapy Market Size (2020-2031)
8.2 Asia-Pacific Gene Detection for Individualized Cancer Therapy Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Gene Detection for Individualized Cancer Therapy Market Size by Region (2020-2025)
8.4 Asia-Pacific Gene Detection for Individualized Cancer Therapy Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Gene Detection for Individualized Cancer Therapy Market Size (2020-2031)
9.2 Latin America Gene Detection for Individualized Cancer Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Gene Detection for Individualized Cancer Therapy Market Size by Country (2020-2025)
9.4 Latin America Gene Detection for Individualized Cancer Therapy Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Gene Detection for Individualized Cancer Therapy Market Size (2020-2031)
10.2 Middle East & Africa Gene Detection for Individualized Cancer Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Gene Detection for Individualized Cancer Therapy Market Size by Country (2020-2025)
10.4 Middle East & Africa Gene Detection for Individualized Cancer Therapy Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Premed
11.1.1 Premed Company Details
11.1.2 Premed Business Overview
11.1.3 Premed Gene Detection for Individualized Cancer Therapy Introduction
11.1.4 Premed Revenue in Gene Detection for Individualized Cancer Therapy Business (2020-2025)
11.1.5 Premed Recent Development
11.2 Yin Feng Gene
11.2.1 Yin Feng Gene Company Details
11.2.2 Yin Feng Gene Business Overview
11.2.3 Yin Feng Gene Gene Detection for Individualized Cancer Therapy Introduction
11.2.4 Yin Feng Gene Revenue in Gene Detection for Individualized Cancer Therapy Business (2020-2025)
11.2.5 Yin Feng Gene Recent Development
11.3 United Gene Group
11.3.1 United Gene Group Company Details
11.3.2 United Gene Group Business Overview
11.3.3 United Gene Group Gene Detection for Individualized Cancer Therapy Introduction
11.3.4 United Gene Group Revenue in Gene Detection for Individualized Cancer Therapy Business (2020-2025)
11.3.5 United Gene Group Recent Development
11.4 Geneis
11.4.1 Geneis Company Details
11.4.2 Geneis Business Overview
11.4.3 Geneis Gene Detection for Individualized Cancer Therapy Introduction
11.4.4 Geneis Revenue in Gene Detection for Individualized Cancer Therapy Business (2020-2025)
11.4.5 Geneis Recent Development
11.5 Topgen
11.5.1 Topgen Company Details
11.5.2 Topgen Business Overview
11.5.3 Topgen Gene Detection for Individualized Cancer Therapy Introduction
11.5.4 Topgen Revenue in Gene Detection for Individualized Cancer Therapy Business (2020-2025)
11.5.5 Topgen Recent Development
11.6 Annoroad
11.6.1 Annoroad Company Details
11.6.2 Annoroad Business Overview
11.6.3 Annoroad Gene Detection for Individualized Cancer Therapy Introduction
11.6.4 Annoroad Revenue in Gene Detection for Individualized Cancer Therapy Business (2020-2025)
11.6.5 Annoroad Recent Development
11.7 Gene+
11.7.1 Gene+ Company Details
11.7.2 Gene+ Business Overview
11.7.3 Gene+ Gene Detection for Individualized Cancer Therapy Introduction
11.7.4 Gene+ Revenue in Gene Detection for Individualized Cancer Therapy Business (2020-2025)
11.7.5 Gene+ Recent Development
11.8 Sanvalley
11.8.1 Sanvalley Company Details
11.8.2 Sanvalley Business Overview
11.8.3 Sanvalley Gene Detection for Individualized Cancer Therapy Introduction
11.8.4 Sanvalley Revenue in Gene Detection for Individualized Cancer Therapy Business (2020-2025)
11.8.5 Sanvalley Recent Development
11.9 Sansure
11.9.1 Sansure Company Details
11.9.2 Sansure Business Overview
11.9.3 Sansure Gene Detection for Individualized Cancer Therapy Introduction
11.9.4 Sansure Revenue in Gene Detection for Individualized Cancer Therapy Business (2020-2025)
11.9.5 Sansure Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Gene Detection for Individualized Cancer Therapy Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Genetic Screening
Table 3. Key Players of Reproductive Genetic Testing
Table 4. Key Players of Diagnostic Test
Table 5. Key Players of Gene carrier Test
Table 6. Key Players of Testing Before Symptoms Appear
Table 7. Global Gene Detection for Individualized Cancer Therapy Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Gene Detection for Individualized Cancer Therapy Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 9. Global Gene Detection for Individualized Cancer Therapy Market Size by Region (2020-2025) & (US$ Million)
Table 10. Global Gene Detection for Individualized Cancer Therapy Market Share by Region (2020-2025)
Table 11. Global Gene Detection for Individualized Cancer Therapy Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 12. Global Gene Detection for Individualized Cancer Therapy Market Share by Region (2026-2031)
Table 13. Gene Detection for Individualized Cancer Therapy Market Trends
Table 14. Gene Detection for Individualized Cancer Therapy Market Drivers
Table 15. Gene Detection for Individualized Cancer Therapy Market Challenges
Table 16. Gene Detection for Individualized Cancer Therapy Market Restraints
Table 17. Global Gene Detection for Individualized Cancer Therapy Revenue by Players (2020-2025) & (US$ Million)
Table 18. Global Gene Detection for Individualized Cancer Therapy Market Share by Players (2020-2025)
Table 19. Global Top Gene Detection for Individualized Cancer Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Detection for Individualized Cancer Therapy as of 2024)
Table 20. Ranking of Global Top Gene Detection for Individualized Cancer Therapy Companies by Revenue (US$ Million) in 2024
Table 21. Global 5 Largest Players Market Share by Gene Detection for Individualized Cancer Therapy Revenue (CR5 and HHI) & (2020-2025)
Table 22. Global Key Players of Gene Detection for Individualized Cancer Therapy, Headquarters and Area Served
Table 23. Global Key Players of Gene Detection for Individualized Cancer Therapy, Product and Application
Table 24. Global Key Players of Gene Detection for Individualized Cancer Therapy, Date of Enter into This Industry
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Gene Detection for Individualized Cancer Therapy Market Size by Type (2020-2025) & (US$ Million)
Table 27. Global Gene Detection for Individualized Cancer Therapy Revenue Market Share by Type (2020-2025)
Table 28. Global Gene Detection for Individualized Cancer Therapy Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 29. Global Gene Detection for Individualized Cancer Therapy Revenue Market Share by Type (2026-2031)
Table 30. Global Gene Detection for Individualized Cancer Therapy Market Size by Application (2020-2025) & (US$ Million)
Table 31. Global Gene Detection for Individualized Cancer Therapy Revenue Market Share by Application (2020-2025)
Table 32. Global Gene Detection for Individualized Cancer Therapy Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 33. Global Gene Detection for Individualized Cancer Therapy Revenue Market Share by Application (2026-2031)
Table 34. North America Gene Detection for Individualized Cancer Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. North America Gene Detection for Individualized Cancer Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 36. North America Gene Detection for Individualized Cancer Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 37. Europe Gene Detection for Individualized Cancer Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 38. Europe Gene Detection for Individualized Cancer Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 39. Europe Gene Detection for Individualized Cancer Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 40. Asia-Pacific Gene Detection for Individualized Cancer Therapy Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 41. Asia-Pacific Gene Detection for Individualized Cancer Therapy Market Size by Region (2020-2025) & (US$ Million)
Table 42. Asia-Pacific Gene Detection for Individualized Cancer Therapy Market Size by Region (2026-2031) & (US$ Million)
Table 43. Latin America Gene Detection for Individualized Cancer Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Latin America Gene Detection for Individualized Cancer Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 45. Latin America Gene Detection for Individualized Cancer Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 46. Middle East & Africa Gene Detection for Individualized Cancer Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 47. Middle East & Africa Gene Detection for Individualized Cancer Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 48. Middle East & Africa Gene Detection for Individualized Cancer Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 49. Premed Company Details
Table 50. Premed Business Overview
Table 51. Premed Gene Detection for Individualized Cancer Therapy Product
Table 52. Premed Revenue in Gene Detection for Individualized Cancer Therapy Business (2020-2025) & (US$ Million)
Table 53. Premed Recent Development
Table 54. Yin Feng Gene Company Details
Table 55. Yin Feng Gene Business Overview
Table 56. Yin Feng Gene Gene Detection for Individualized Cancer Therapy Product
Table 57. Yin Feng Gene Revenue in Gene Detection for Individualized Cancer Therapy Business (2020-2025) & (US$ Million)
Table 58. Yin Feng Gene Recent Development
Table 59. United Gene Group Company Details
Table 60. United Gene Group Business Overview
Table 61. United Gene Group Gene Detection for Individualized Cancer Therapy Product
Table 62. United Gene Group Revenue in Gene Detection for Individualized Cancer Therapy Business (2020-2025) & (US$ Million)
Table 63. United Gene Group Recent Development
Table 64. Geneis Company Details
Table 65. Geneis Business Overview
Table 66. Geneis Gene Detection for Individualized Cancer Therapy Product
Table 67. Geneis Revenue in Gene Detection for Individualized Cancer Therapy Business (2020-2025) & (US$ Million)
Table 68. Geneis Recent Development
Table 69. Topgen Company Details
Table 70. Topgen Business Overview
Table 71. Topgen Gene Detection for Individualized Cancer Therapy Product
Table 72. Topgen Revenue in Gene Detection for Individualized Cancer Therapy Business (2020-2025) & (US$ Million)
Table 73. Topgen Recent Development
Table 74. Annoroad Company Details
Table 75. Annoroad Business Overview
Table 76. Annoroad Gene Detection for Individualized Cancer Therapy Product
Table 77. Annoroad Revenue in Gene Detection for Individualized Cancer Therapy Business (2020-2025) & (US$ Million)
Table 78. Annoroad Recent Development
Table 79. Gene+ Company Details
Table 80. Gene+ Business Overview
Table 81. Gene+ Gene Detection for Individualized Cancer Therapy Product
Table 82. Gene+ Revenue in Gene Detection for Individualized Cancer Therapy Business (2020-2025) & (US$ Million)
Table 83. Gene+ Recent Development
Table 84. Sanvalley Company Details
Table 85. Sanvalley Business Overview
Table 86. Sanvalley Gene Detection for Individualized Cancer Therapy Product
Table 87. Sanvalley Revenue in Gene Detection for Individualized Cancer Therapy Business (2020-2025) & (US$ Million)
Table 88. Sanvalley Recent Development
Table 89. Sansure Company Details
Table 90. Sansure Business Overview
Table 91. Sansure Gene Detection for Individualized Cancer Therapy Product
Table 92. Sansure Revenue in Gene Detection for Individualized Cancer Therapy Business (2020-2025) & (US$ Million)
Table 93. Sansure Recent Development
Table 94. Research Programs/Design for This Report
Table 95. Key Data Information from Secondary Sources
Table 96. Key Data Information from Primary Sources
Table 97. Authors List of This Report
List of Figures
Figure 1. Gene Detection for Individualized Cancer Therapy Picture
Figure 2. Global Gene Detection for Individualized Cancer Therapy Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Gene Detection for Individualized Cancer Therapy Market Share by Type: 2024 VS 2031
Figure 4. Genetic Screening Features
Figure 5. Reproductive Genetic Testing Features
Figure 6. Diagnostic Test Features
Figure 7. Gene carrier Test Features
Figure 8. Testing Before Symptoms Appear Features
Figure 9. Global Gene Detection for Individualized Cancer Therapy Market Size by Application (2020-2031) & (US$ Million)
Figure 10. Global Gene Detection for Individualized Cancer Therapy Market Share by Application: 2024 VS 2031
Figure 11. Hospital Case Studies
Figure 12. Clinic Case Studies
Figure 13. Diagnostic Center Case Studies
Figure 14. Gene Detection for Individualized Cancer Therapy Report Years Considered
Figure 15. Global Gene Detection for Individualized Cancer Therapy Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 16. Global Gene Detection for Individualized Cancer Therapy Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 17. Global Gene Detection for Individualized Cancer Therapy Market Share by Region: 2024 VS 2031
Figure 18. Global Gene Detection for Individualized Cancer Therapy Market Share by Players in 2024
Figure 19. Global Top Gene Detection for Individualized Cancer Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Detection for Individualized Cancer Therapy as of 2024)
Figure 20. The Top 10 and 5 Players Market Share by Gene Detection for Individualized Cancer Therapy Revenue in 2024
Figure 21. North America Gene Detection for Individualized Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. North America Gene Detection for Individualized Cancer Therapy Market Share by Country (2020-2031)
Figure 23. United States Gene Detection for Individualized Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Canada Gene Detection for Individualized Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Gene Detection for Individualized Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Europe Gene Detection for Individualized Cancer Therapy Market Share by Country (2020-2031)
Figure 27. Germany Gene Detection for Individualized Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. France Gene Detection for Individualized Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. U.K. Gene Detection for Individualized Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Italy Gene Detection for Individualized Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Russia Gene Detection for Individualized Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Nordic Countries Gene Detection for Individualized Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Gene Detection for Individualized Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Asia-Pacific Gene Detection for Individualized Cancer Therapy Market Share by Region (2020-2031)
Figure 35. China Gene Detection for Individualized Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Japan Gene Detection for Individualized Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. South Korea Gene Detection for Individualized Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Southeast Asia Gene Detection for Individualized Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. India Gene Detection for Individualized Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Australia Gene Detection for Individualized Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Gene Detection for Individualized Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Latin America Gene Detection for Individualized Cancer Therapy Market Share by Country (2020-2031)
Figure 43. Mexico Gene Detection for Individualized Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Brazil Gene Detection for Individualized Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Gene Detection for Individualized Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Middle East & Africa Gene Detection for Individualized Cancer Therapy Market Share by Country (2020-2031)
Figure 47. Turkey Gene Detection for Individualized Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Saudi Arabia Gene Detection for Individualized Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. UAE Gene Detection for Individualized Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. Premed Revenue Growth Rate in Gene Detection for Individualized Cancer Therapy Business (2020-2025)
Figure 51. Yin Feng Gene Revenue Growth Rate in Gene Detection for Individualized Cancer Therapy Business (2020-2025)
Figure 52. United Gene Group Revenue Growth Rate in Gene Detection for Individualized Cancer Therapy Business (2020-2025)
Figure 53. Geneis Revenue Growth Rate in Gene Detection for Individualized Cancer Therapy Business (2020-2025)
Figure 54. Topgen Revenue Growth Rate in Gene Detection for Individualized Cancer Therapy Business (2020-2025)
Figure 55. Annoroad Revenue Growth Rate in Gene Detection for Individualized Cancer Therapy Business (2020-2025)
Figure 56. Gene+ Revenue Growth Rate in Gene Detection for Individualized Cancer Therapy Business (2020-2025)
Figure 57. Sanvalley Revenue Growth Rate in Gene Detection for Individualized Cancer Therapy Business (2020-2025)
Figure 58. Sansure Revenue Growth Rate in Gene Detection for Individualized Cancer Therapy Business (2020-2025)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
Table 1. Global Gene Detection for Individualized Cancer Therapy Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Genetic Screening
Table 3. Key Players of Reproductive Genetic Testing
Table 4. Key Players of Diagnostic Test
Table 5. Key Players of Gene carrier Test
Table 6. Key Players of Testing Before Symptoms Appear
Table 7. Global Gene Detection for Individualized Cancer Therapy Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Gene Detection for Individualized Cancer Therapy Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 9. Global Gene Detection for Individualized Cancer Therapy Market Size by Region (2020-2025) & (US$ Million)
Table 10. Global Gene Detection for Individualized Cancer Therapy Market Share by Region (2020-2025)
Table 11. Global Gene Detection for Individualized Cancer Therapy Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 12. Global Gene Detection for Individualized Cancer Therapy Market Share by Region (2026-2031)
Table 13. Gene Detection for Individualized Cancer Therapy Market Trends
Table 14. Gene Detection for Individualized Cancer Therapy Market Drivers
Table 15. Gene Detection for Individualized Cancer Therapy Market Challenges
Table 16. Gene Detection for Individualized Cancer Therapy Market Restraints
Table 17. Global Gene Detection for Individualized Cancer Therapy Revenue by Players (2020-2025) & (US$ Million)
Table 18. Global Gene Detection for Individualized Cancer Therapy Market Share by Players (2020-2025)
Table 19. Global Top Gene Detection for Individualized Cancer Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Detection for Individualized Cancer Therapy as of 2024)
Table 20. Ranking of Global Top Gene Detection for Individualized Cancer Therapy Companies by Revenue (US$ Million) in 2024
Table 21. Global 5 Largest Players Market Share by Gene Detection for Individualized Cancer Therapy Revenue (CR5 and HHI) & (2020-2025)
Table 22. Global Key Players of Gene Detection for Individualized Cancer Therapy, Headquarters and Area Served
Table 23. Global Key Players of Gene Detection for Individualized Cancer Therapy, Product and Application
Table 24. Global Key Players of Gene Detection for Individualized Cancer Therapy, Date of Enter into This Industry
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Gene Detection for Individualized Cancer Therapy Market Size by Type (2020-2025) & (US$ Million)
Table 27. Global Gene Detection for Individualized Cancer Therapy Revenue Market Share by Type (2020-2025)
Table 28. Global Gene Detection for Individualized Cancer Therapy Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 29. Global Gene Detection for Individualized Cancer Therapy Revenue Market Share by Type (2026-2031)
Table 30. Global Gene Detection for Individualized Cancer Therapy Market Size by Application (2020-2025) & (US$ Million)
Table 31. Global Gene Detection for Individualized Cancer Therapy Revenue Market Share by Application (2020-2025)
Table 32. Global Gene Detection for Individualized Cancer Therapy Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 33. Global Gene Detection for Individualized Cancer Therapy Revenue Market Share by Application (2026-2031)
Table 34. North America Gene Detection for Individualized Cancer Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. North America Gene Detection for Individualized Cancer Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 36. North America Gene Detection for Individualized Cancer Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 37. Europe Gene Detection for Individualized Cancer Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 38. Europe Gene Detection for Individualized Cancer Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 39. Europe Gene Detection for Individualized Cancer Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 40. Asia-Pacific Gene Detection for Individualized Cancer Therapy Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 41. Asia-Pacific Gene Detection for Individualized Cancer Therapy Market Size by Region (2020-2025) & (US$ Million)
Table 42. Asia-Pacific Gene Detection for Individualized Cancer Therapy Market Size by Region (2026-2031) & (US$ Million)
Table 43. Latin America Gene Detection for Individualized Cancer Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Latin America Gene Detection for Individualized Cancer Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 45. Latin America Gene Detection for Individualized Cancer Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 46. Middle East & Africa Gene Detection for Individualized Cancer Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 47. Middle East & Africa Gene Detection for Individualized Cancer Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 48. Middle East & Africa Gene Detection for Individualized Cancer Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 49. Premed Company Details
Table 50. Premed Business Overview
Table 51. Premed Gene Detection for Individualized Cancer Therapy Product
Table 52. Premed Revenue in Gene Detection for Individualized Cancer Therapy Business (2020-2025) & (US$ Million)
Table 53. Premed Recent Development
Table 54. Yin Feng Gene Company Details
Table 55. Yin Feng Gene Business Overview
Table 56. Yin Feng Gene Gene Detection for Individualized Cancer Therapy Product
Table 57. Yin Feng Gene Revenue in Gene Detection for Individualized Cancer Therapy Business (2020-2025) & (US$ Million)
Table 58. Yin Feng Gene Recent Development
Table 59. United Gene Group Company Details
Table 60. United Gene Group Business Overview
Table 61. United Gene Group Gene Detection for Individualized Cancer Therapy Product
Table 62. United Gene Group Revenue in Gene Detection for Individualized Cancer Therapy Business (2020-2025) & (US$ Million)
Table 63. United Gene Group Recent Development
Table 64. Geneis Company Details
Table 65. Geneis Business Overview
Table 66. Geneis Gene Detection for Individualized Cancer Therapy Product
Table 67. Geneis Revenue in Gene Detection for Individualized Cancer Therapy Business (2020-2025) & (US$ Million)
Table 68. Geneis Recent Development
Table 69. Topgen Company Details
Table 70. Topgen Business Overview
Table 71. Topgen Gene Detection for Individualized Cancer Therapy Product
Table 72. Topgen Revenue in Gene Detection for Individualized Cancer Therapy Business (2020-2025) & (US$ Million)
Table 73. Topgen Recent Development
Table 74. Annoroad Company Details
Table 75. Annoroad Business Overview
Table 76. Annoroad Gene Detection for Individualized Cancer Therapy Product
Table 77. Annoroad Revenue in Gene Detection for Individualized Cancer Therapy Business (2020-2025) & (US$ Million)
Table 78. Annoroad Recent Development
Table 79. Gene+ Company Details
Table 80. Gene+ Business Overview
Table 81. Gene+ Gene Detection for Individualized Cancer Therapy Product
Table 82. Gene+ Revenue in Gene Detection for Individualized Cancer Therapy Business (2020-2025) & (US$ Million)
Table 83. Gene+ Recent Development
Table 84. Sanvalley Company Details
Table 85. Sanvalley Business Overview
Table 86. Sanvalley Gene Detection for Individualized Cancer Therapy Product
Table 87. Sanvalley Revenue in Gene Detection for Individualized Cancer Therapy Business (2020-2025) & (US$ Million)
Table 88. Sanvalley Recent Development
Table 89. Sansure Company Details
Table 90. Sansure Business Overview
Table 91. Sansure Gene Detection for Individualized Cancer Therapy Product
Table 92. Sansure Revenue in Gene Detection for Individualized Cancer Therapy Business (2020-2025) & (US$ Million)
Table 93. Sansure Recent Development
Table 94. Research Programs/Design for This Report
Table 95. Key Data Information from Secondary Sources
Table 96. Key Data Information from Primary Sources
Table 97. Authors List of This Report
List of Figures
Figure 1. Gene Detection for Individualized Cancer Therapy Picture
Figure 2. Global Gene Detection for Individualized Cancer Therapy Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Gene Detection for Individualized Cancer Therapy Market Share by Type: 2024 VS 2031
Figure 4. Genetic Screening Features
Figure 5. Reproductive Genetic Testing Features
Figure 6. Diagnostic Test Features
Figure 7. Gene carrier Test Features
Figure 8. Testing Before Symptoms Appear Features
Figure 9. Global Gene Detection for Individualized Cancer Therapy Market Size by Application (2020-2031) & (US$ Million)
Figure 10. Global Gene Detection for Individualized Cancer Therapy Market Share by Application: 2024 VS 2031
Figure 11. Hospital Case Studies
Figure 12. Clinic Case Studies
Figure 13. Diagnostic Center Case Studies
Figure 14. Gene Detection for Individualized Cancer Therapy Report Years Considered
Figure 15. Global Gene Detection for Individualized Cancer Therapy Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 16. Global Gene Detection for Individualized Cancer Therapy Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 17. Global Gene Detection for Individualized Cancer Therapy Market Share by Region: 2024 VS 2031
Figure 18. Global Gene Detection for Individualized Cancer Therapy Market Share by Players in 2024
Figure 19. Global Top Gene Detection for Individualized Cancer Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Detection for Individualized Cancer Therapy as of 2024)
Figure 20. The Top 10 and 5 Players Market Share by Gene Detection for Individualized Cancer Therapy Revenue in 2024
Figure 21. North America Gene Detection for Individualized Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. North America Gene Detection for Individualized Cancer Therapy Market Share by Country (2020-2031)
Figure 23. United States Gene Detection for Individualized Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Canada Gene Detection for Individualized Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Gene Detection for Individualized Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Europe Gene Detection for Individualized Cancer Therapy Market Share by Country (2020-2031)
Figure 27. Germany Gene Detection for Individualized Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. France Gene Detection for Individualized Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. U.K. Gene Detection for Individualized Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Italy Gene Detection for Individualized Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Russia Gene Detection for Individualized Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Nordic Countries Gene Detection for Individualized Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Gene Detection for Individualized Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Asia-Pacific Gene Detection for Individualized Cancer Therapy Market Share by Region (2020-2031)
Figure 35. China Gene Detection for Individualized Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Japan Gene Detection for Individualized Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. South Korea Gene Detection for Individualized Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Southeast Asia Gene Detection for Individualized Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. India Gene Detection for Individualized Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Australia Gene Detection for Individualized Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Gene Detection for Individualized Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Latin America Gene Detection for Individualized Cancer Therapy Market Share by Country (2020-2031)
Figure 43. Mexico Gene Detection for Individualized Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Brazil Gene Detection for Individualized Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Gene Detection for Individualized Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Middle East & Africa Gene Detection for Individualized Cancer Therapy Market Share by Country (2020-2031)
Figure 47. Turkey Gene Detection for Individualized Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Saudi Arabia Gene Detection for Individualized Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. UAE Gene Detection for Individualized Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. Premed Revenue Growth Rate in Gene Detection for Individualized Cancer Therapy Business (2020-2025)
Figure 51. Yin Feng Gene Revenue Growth Rate in Gene Detection for Individualized Cancer Therapy Business (2020-2025)
Figure 52. United Gene Group Revenue Growth Rate in Gene Detection for Individualized Cancer Therapy Business (2020-2025)
Figure 53. Geneis Revenue Growth Rate in Gene Detection for Individualized Cancer Therapy Business (2020-2025)
Figure 54. Topgen Revenue Growth Rate in Gene Detection for Individualized Cancer Therapy Business (2020-2025)
Figure 55. Annoroad Revenue Growth Rate in Gene Detection for Individualized Cancer Therapy Business (2020-2025)
Figure 56. Gene+ Revenue Growth Rate in Gene Detection for Individualized Cancer Therapy Business (2020-2025)
Figure 57. Sanvalley Revenue Growth Rate in Gene Detection for Individualized Cancer Therapy Business (2020-2025)
Figure 58. Sansure Revenue Growth Rate in Gene Detection for Individualized Cancer Therapy Business (2020-2025)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Electrolytes for Lithium-Ion Batteries Market Research Report 2025
Jul 14, 25
Global Vanadium Products Market Research Report 2025
Jul 14, 25
Global High-purity Vanadium Oxide Market Research Report 2025
Jul 14, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232